Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes
Summary
Our understanding of the biological role of the Y chromosome remains limited. Here, we systematically profile germline Y haplogroups and somatic loss of the Y chromosome (LOY) in 122,683 East Asian males from BioBank Japan and 181,472 European males from the UK Biobank. A phenome-wide scan uncovers male-specific genetic regulation of complex traits, including pleiotropic effects of the Japanese-specific haplogroup D on height and type 2 diabetes (T2D). LOY increases T2D risk in East Asians
Content
# Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes
*Published: 2026 Mar*
Our understanding of the biological role of the Y chromosome remains limited.
Here, we systematically profile germline Y haplogroups and somatic loss of the Y
chromosome (LOY) in 122,683 East Asian males from BioBank Japan and 181,472
European males from the UK Biobank. A phenome-wide scan uncovers male-specific
genetic regulation of complex traits, including pleiotropic effects of the
Japanese-specific haplogroup D on height and type 2 diabetes (T2D). LOY
increases T2D risk in East Asians but is associated with reduced T2D risk in
Europeans. In East Asians, LOY contributes to T2D incidence particularly among
males with lower polygenic risk scores, providing a compensatory explanation for
disease risk beyond germline genetics. Incorporating sex-chromosome variation
improves polygenic prediction of T2D risk in both sexes. Single-cell analyses
reveal cell type-specific accumulation of LOY across tissues and disease
contexts, with LOY in pancreatic β cells potentially impairing glucose
metabolism. Our study demonstrates the clinical relevance of Y chromosome
variation for diabetes risk prediction and management.
DOI: 10.1038/s41591-026-04213-z